Peter Catalano is our Head of Finance and oversees our finance, accounting, and treasury functions.
Prior to joining Alchemab, Peter served as the Senior Finance Manager – Immunology at Janssen Pharmaceuticals Companies of Johnson & Johnson, where he managed the Immunology R&D portfolio and the integration of the Momenta Pharmaceuticals finance and accounting functions following its acquisition by Johnson & Johnson.
Before Janssen Pharmaceuticals, Peter was the Assistant Controller at Momenta Pharmaceuticals where he was responsible for various aspects of the finance and accounting function. Prior to Momenta, Peter served in positions of increasing responsibility at Ernst & Young.
Peter is a Certified Public Accountant in the state of Massachusetts and earned his M.S. degree in Accounting and a B.S. degree in Corporate Finance and Accounting from Bentley University.